O

    Orchestra BioMed Holdings Inc. (OBIO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $5.04
    -0.14 (-2.80%)

    Market Cap: $311.64M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    73%(11/15)
    Avg Surprise
    +17.70%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.37
    Range$-0.41 - $-0.28
    5 analysts
    EPS Revisions
    4
    0
    7d
    4
    1
    30d
    EPS Estimate Drift
    90d ago$-0.44-19.0%
    60d ago$-0.41-11.2%
    30d ago$-0.37+0.0%
    7d ago$-0.37+0.0%
    Current$-0.37
    Revenue Consensus
    $118170
    Range$100000 - $162000
    6 analysts
    Dec 31, 2026
    EPS Consensus$-0.34
    Range$-0.46 - $-0.27
    4 analysts
    Revenue Consensus
    $6330
    Range$-34170 - $102830
    6 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.34---
    Sep 26EST
    		-$-0.37---
    Jun 26
    		$-0.38$-0.35-8.57%Miss+24.0%
    Mar 26
    		$-0.33$-0.44+25.55%Beat+32.8%
    Dec 25
    		$0.26$-0.38+168.42%Beat+161.9%
    Sep 25
    		$-0.40$-0.43+6.98%Beat+2.4%
    Jun 25
    		$-0.50$-0.51+1.96%Beat-11.1%
    Mar 25
    		$-0.49$-0.48-2.08%Miss-28.9%
    Dec 24
    		$-0.42$-0.45+6.67%Beat-13.5%
    Sep 24
    		$-0.41$-0.44+6.82%Beat-7.9%
    Jun 24
    		$-0.45$-0.40-12.50%Miss-28.6%
    Mar 24
    		$-0.38$-0.38+0.00%Beat+5.0%
    Dec 23
    		$-0.37$-0.38+2.63%Beat-362.5%
    Sep 23
    		$-0.38$-0.39+2.56%Beat-660.0%
    Jun 23
    		$-0.35$-0.41+14.63%Beat-775.0%
    Mar 23
    		$-0.40$-0.28-42.86%Miss-1900.0%
    Dec 22
    		$-0.08N/A+95.32%Beat-1760.5%
    Sep 22
    		$-0.05$0.00N/AMiss-1036.4%
    Jun 22
    		$-0.04$0.00N/AMiss-788.9%
    Mar 22
    		$-0.02$0.00N/AMiss-100.0%
    Dec 21
    		$-0.00$0.00N/AMiss+57.0%
    Sep 21
    		$-0.00$0.00N/AMiss-37.5%
    Jun 21
    		$-0.00$0.00N/AMiss-
    Mar 21
    		$-0.01$0.00N/AMiss-
    Dec 20
    		$-0.01$0.00N/AMiss-
    Sep 20
    		$-0.00$0.00N/AMiss-
    Jun 20
    		$0.00$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-5.93EV/EBITDA-1.81x
    Price/FCF-5.44xFCF Yield-18.38%
    Profitability
    Profit Margin-184.60%Operating Margin-25405.00%
    ROE-397.30%ROIC-84.10%
    Financial Health
    Debt/Equity1.80xInterest CoverageN/A
    Current Ratio8.26xQuick Ratio8.24x
    Trading Statistics
    Beta0.50Avg Volume310.81K
    52-Week High$5.7852-Week Low$2.20

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$5.34
    SMA 20$4.86
    SMA 50$4.31
    SMA 200$4.26
    EMA 10$5.13
    EMA 20$4.90
    EMA 50$4.50
    EMA 200$4.14

    MACD

    Line: 0.31Signal: 0.32Hist: -0.01

    ADX

    ADX: 35.3+DI: 29.6-DI: 15.9

    Aroon & PSAR

    Aroon Up68.0
    Aroon DownN/A
    PSAR$5.70

    Bollinger Bands

    Upper Band$5.91
    Lower Band$3.81
    %B Position4325%(Upper)
    Band Width0.59

    RSI (14-Day)

    Neutral
    58.2

    Momentum Oscillators

    Stoch %K57.7
    Stoch %D62.6
    Williams %R-46.8
    ROC (10d)6.8%
    Momentum0.32
    CCI (20d)38.1
    MFI (14d)60.3

    Volatility Measures

    ATR (14d)$0.27(5.3%)
    StdDev (20d)0.53
    Hist Vol82.2%(High)

    Volume Flow

    VWAP$5.13
    OBV16.1M
    AD Line-1.4M
    CMF (20d)0.200

    Volume Metrics

    Avg Vol (20d)317.0K
    Vol Ratio0.9x
    VWMA (20d)$5.16

    Pivot Points

    R3$5.43
    R2$5.33
    R1$5.26
    Pivot Point$5.16
    S1$5.09
    S2$4.99
    S3$4.92

    Advanced Oscillators

    TSI34.26
    Ultimate Osc43.6
    KST315.62

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$88,000$110,000$30.92M$861,000$836,000$868,000$253,000$987,000$778,000$620,000$262,000$419,000
    Cost of Revenue$25,000$32,000$51,000$49,000$46,000$44,000$58,000$68,000$44,000$34,000$47,000$41,000
    Gross Profit$63,000$78,000$30.87M$812,000$790,000$824,000$195,000$919,000$734,000$586,000$215,000$378,000
    Operating Expenses$22.42M$22.15M$24.11M$21.13M$20.12M$19.75M$16.87M$17.26M$17.59M$15.01M$12.70M$14.90M
    R&D$16.59M$15.78M$16.82M$14.03M$13.85M$13.48M$10.97M$11.60M$11.13M$9.11M$8.51M$8.56M
    SG&A$5.83M$6.37M$7.29M$7.10M$6.26M$6.26M$5.90M$5.67M$6.47M$5.90M$4.18M$6.34M
    Operating Income$-22,356,000$-22,076,000$6.75M$-20,313,000$-19,327,000$-18,921,000$-16,677,000$-16,342,000$-16,859,000$-14,423,000$-12,481,000$-14,524,000
    Interest Income$-1,768,000$1.42M$-763,000$-515,000$-36,000$166,000$522,000$916,000$879,000$971,000$2.64M$1.21M
    Interest Expense$1.40M$0$763,000$515,000$36,000$0$0$0$0$0$337,000$0
    Income Before Tax$-23,755,000$-20,691,000$5.99M$-20,828,000$-19,363,000$-18,755,000$-16,155,000$-15,426,000$-15,980,000$-13,463,000$-12,818,000$-13,316,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-23,755,000$-20,691,000$6.25M$-20,828,000$-19,363,000$-18,755,000$-16,155,000$-15,426,000$-15,980,000$-13,463,000$-12,818,000$-13,316,000
    EBITDA$-22,225,000$-22,034,000$6.58M$-20,503,000$-19,249,000$-18,904,000$-16,793,000$-16,622,000$-17,110,000$-14,949,000$-13,044,000$-15,480,000
    EBIT$-21,987,000$-22,111,000$6.75M$-20,313,000$-19,327,000$-18,921,000$-16,677,000$-16,342,000$-16,859,000$-14,434,000$-12,481,000$-14,524,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about OBIO

    News

    Orchestra BioMed to Participate in the Wells Fargo 21st Annual Healthcare Conference

    Orchestra BioMed Holdings, Inc. announced that its Chairman and CEO, David Hochman, will present at the Wells Fargo 21st Annual Healthcare Conference on September 10, 2026, and host one-on-one investor meetings. The company will provide a live webcast of the event on its Investor Relations website. Orchestra BioMed focuses on accelerating high-impact medical technologies like AVIM Therapy for hypertension and Virtue® Sirolimus AngioInfusion™ Balloon for atherosclerotic artery disease.

    Yahoo Finance•8/20/26•
    Bullish

    Insiders Buying Orchestra BioMed Holdings Might Wish They Invested More, Stock Gains 29%

    Orchestra BioMed Holdings (NASDAQ:OBIO) insiders, specifically those who bought stock in the last year at an average price of US$7.28, have seen their investment rise by 29%. Despite this positive return, the article suggests that they might wish they had invested more, as the stock has performed well. The company's market capitalization stands at US$177m.

    Moomoo•8/19/26•
    Bullish

    Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Receives Consensus Rating of "Moderate Buy" from Brokerages

    Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) has received a "Moderate Buy" consensus rating from brokerages, with an average 12-month price target of $13.00, significantly higher than its current share price of $4.41. The company recently reported a quarterly loss that was slightly better than expected, though revenue fell short of estimates. Insider Darren Sherman sold 15,000 shares, and institutional ownership stands at 53.2%.

    MarketBeat•8/16/26•
    Somewhat-Bullish

    Orchestra BioMed (OBIO) director uses 5,145 shares to cover RSU tax withholding

    Orchestra BioMed Holdings, Inc. director Eric S. Fain reported an indirect disposition of 5,145 common stock shares on August 12, 2026. These shares were withheld by the company to satisfy tax withholding obligations related to the vesting of restricted stock units (RSUs) and no shares were sold in the market. Following this transaction, The Fain Living Trust indirectly holds 99,630 shares.

    Stock Titan•8/15/26•
    Neutral

    Orchestra BioMed (OBIO) director reports 4,238 RSU tax-withholding shares

    Orchestra BioMed Holdings, Inc. director Chris Cleary reported a Form 4 transaction where 4,238 shares of common stock were withheld by the company on August 12, 2026, to satisfy tax withholding obligations upon the vesting of restricted stock units (RSUs). No shares were sold in the market as a result of this transaction. Following this, Cleary directly holds 29,153 common shares, with the withheld shares valued at $4.42 each.

    Stock Titan•8/14/26•
    Neutral

    Frequently Asked Questions About OBIO

    Does OBIO pay dividends?
    Orchestra BioMed Holdings Inc. (OBIO) does not currently pay a regular dividend.
    What is OBIO's market cap?
    Orchestra BioMed Holdings Inc. (OBIO) has a market capitalization of $311.64M with a current stock price of $5.04.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In